Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care.
作者信息
Cheng Richard K, Kirkpatrick James N, Sorror Mohamed L, Barac Ana
机构信息
Division of Cardiology, University of Washington School of Medicine, Seattle, Washington, USA.
Fred Hutchinson Cancer Research Center and Division of Oncology, University of Washington School of Medicine, Seattle, Washington, USA.
出版信息
JACC CardioOncol. 2019 Dec 17;1(2):314-317. doi: 10.1016/j.jaccao.2019.10.003. eCollection 2019 Dec.
Abstract
摘要
相似文献
1
Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care.心脏肿瘤学以及癌症与心脏毒性的交叉领域：姑息治疗的作用
JACC CardioOncol. 2019 Dec 17;1(2):314-317. doi: 10.1016/j.jaccao.2019.10.003. eCollection 2019 Dec.
2
Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.巴西心血管肿瘤学：圣保罗州立癌症研究所的 10 年经验。
BMC Cardiovasc Disord. 2020 Apr 28;20(1):206. doi: 10.1186/s12872-020-01471-8.
3
Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.心脏肿瘤学概念：癌症治疗引起的心脏毒性的定义、机制、诊断和治疗策略
Future Oncol. 2016 Mar;12(6):855-70. doi: 10.2217/fon.15.349. Epub 2016 Feb 1.
4
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.血清生物标志物在接受心脏毒性癌症治疗的癌症患者中的作用：心力衰竭协会的心脏肿瘤学研究小组和欧洲心脏病学会的心脏肿瘤学理事会的立场声明。
Eur J Heart Fail. 2020 Nov;22(11):1966-1983. doi: 10.1002/ejhf.2017. Epub 2020 Oct 20.
5
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.澳大利亚和新西兰心血管肿瘤登记处：全国儿科癌症患者队列中化疗相关心脏毒性的评估。
Intern Med J. 2021 Feb;51(2):229-234. doi: 10.1111/imj.14719.
6
Organization and implementation of a cardio-oncology program.心脏肿瘤项目的组织与实施
Rev Port Cardiol. 2016 Sep;35(9):485-94. doi: 10.1016/j.repc.2016.04.006. Epub 2016 Aug 5.
7
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.设立心脏肿瘤学科室的基本原理：我们在梅奥诊所的经验。
Cardiooncology. 2016 Apr 19;2(1):5. doi: 10.1186/s40959-016-0014-2.
8
The Role of Biomarkers in Cardio-Oncology.生物标志物在心肿瘤学中的作用。
J Cardiovasc Transl Res. 2020 Jun;13(3):431-450. doi: 10.1007/s12265-020-10042-3. Epub 2020 Jul 8.
9
10
Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians.癌症治疗引起的心脏毒性的评估、预防与管理：临床医生的现代方法
Curr Opin Cardiol. 2015 Mar;30(2):197-204. doi: 10.1097/HCO.0000000000000145.
引用本文的文献
1
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council Perspective.心脏肿瘤学的医疗质量指标：国际心脏肿瘤学会（IC-OS）和美国心脏病学会（ACC）心脏肿瘤学领导委员会观点
JACC CardioOncol. 2025 Apr;7(3):191-202. doi: 10.1016/j.jaccao.2024.11.003. Epub 2025 Jan 7.
2
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America.心脏肿瘤学与心力衰竭：美国心力衰竭学会科学声明
J Card Fail. 2025 Feb;31(2):415-455. doi: 10.1016/j.cardfail.2024.08.045. Epub 2024 Oct 15.
3
Left Ventricular Assist Devices in Patients With Active Malignancies.患有活动性恶性肿瘤患者的左心室辅助装置
JACC CardioOncol. 2021 Jun 15;3(2):305-315. doi: 10.1016/j.jaccao.2021.04.008. eCollection 2021 Jun.
4
Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity.基于单克隆抗体的免疫疗法及其在心脏毒性发生中的作用。
Cancers (Basel). 2020 Dec 30;13(1):86. doi: 10.3390/cancers13010086.
本文引用的文献
1
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.2017年美国心脏病学会（ACC）心力衰竭治疗优化专家共识决策路径：关于射血分数降低的心力衰竭10个关键问题的解答：美国心脏病学会专家共识决策路径特别工作组报告
J Am Coll Cardiol. 2018 Jan 16;71(2):201-230. doi: 10.1016/j.jacc.2017.11.025. Epub 2017 Dec 22.
2
Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities.心力衰竭的姑息治疗：基本原理、证据及未来重点
J Am Coll Cardiol. 2017 Oct 10;70(15):1919-1930. doi: 10.1016/j.jacc.2017.08.036.
3
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.心力衰竭的姑息治疗：PAL-HF随机对照临床试验
J Am Coll Cardiol. 2017 Jul 18;70(3):331-341. doi: 10.1016/j.jacc.2017.05.030.
4
Standardized Criteria for Palliative Care Consultation on a Solid Tumor Oncology Service Reduces Downstream Health Care Use.实体肿瘤肿瘤学服务中姑息治疗咨询的标准化标准可减少下游医疗保健的使用。
J Oncol Pract. 2017 May;13(5):e431-e440. doi: 10.1200/JOP.2016.016808. Epub 2017 Mar 17.
5
Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-analysis.姑息治疗与患者及照护者结局之间的关联：一项系统评价与荟萃分析
JAMA. 2016 Nov 22;316(20):2104-2114. doi: 10.1001/jama.2016.16840.
6
Future of the Palliative Care Workforce: Preview to an Impending Crisis.姑息治疗劳动力的未来：即将到来的危机预览。
Am J Med. 2017 Feb;130(2):113-114. doi: 10.1016/j.amjmed.2016.08.046. Epub 2016 Sep 26.
Zotero 插件